Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer

Bookmark and Share
Published: 18 Dec 2019
Views: 358
Rating:
Save
Prof Masakazu Toi - Kyoto University, Kyoto, Japan

Prof Masakazu Toi gives a press conference at the 2019 San Antonio Breast Cancer Symposium about the addition of S-1 to post-operative endocrine therapy in patients with hormone receptor-positive, HER2-negative breast cancer.

Watch our interview with Prof Masakazu Toi here

Read more about the study here